![](https://investorshub.advfn.com/uicon/505590.png?cb=1501536884)
Monday, August 31, 2015 7:23:36 AM
I'll even lay it out for people in this forgotten little tributary. It's so quiet, I can almost hear myself think.
1. On May 7th, 2015 LP stated the IA would occur in the coming month. That is month -- singular. I do not think she stated months, but it is arguable.
2. Quiet period. Basically after June 3rd, 2015 up through today, NWBO has not released any promotional PRs other than when they were recently forced to respond.
3. At least since July 13, 2015, the London conference for the 16th/17th of September lists NWBO as the lead sponsor, they present twice and engage in a round table, etc.
4. On approximately August 3rd, 2015, NWBO temporarily suspended screening, and recently announced they plan to file documents for review by regulatory authorities.
5. On August 17th, 2015, by looking up the construction code notifications, a clever reporter determined Cognate was engaged in a 9+ million dollar, 80 employee manufacturing expansion . From my perspective, the article clearly was referring to POST STUDY expansion to handle DCVax-L ramping.
6. On August 21st, 2015 NWBO stated they would file those documents with regulatory authorities on approximately September 4, 2015.
7. On August 25th, 2015 NWBO stated that negative bloggers and commentators were trying to turn good news into bad news about the trial and their company.
8. On August 27th, 2015, Senti/Koman confirmed the screening suspension was for the entire trial not just Germany. They learned this by calling some clinics.
9. On August 29th, 2015, RRR called 10 clinics, and he learned that the clinics stopped recruiting approximately August 3, 2015. The assumption was that NWBO would be seeking approval. Which is consistent with what NWBO has stated repeatedly -- they would file for accelerated approval if results were similar to phase I/II results.
10. September 4, 2015. Approximate date NWBO will file documents with regulatory authorities.
11. September 16th/17th. End of quiet period
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM